Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration.
Acute bacterial or fungal infection requiring intravenous antibiotics within 7 days of enrollment;
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Severe, active comorbidity, defined as follows:\r\n* Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration\r\n* Active Crohn’s disease or ulcerative colitis\r\n* Scleroderma
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration or within 2 weeks of cycle 1 day 1.
Have active bacterial or fungal infection (that is, requiring intravenous antibiotics at the time of initiating study treatment) and/or detectable viral infection.
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration.
Acute bacterial or fungal infection requiring intravenous antibiotics at the time of randomization